The latest update is out from Shuttle Pharmaceuticals Holdings, Inc. ( (SHPH) ).
On February 28, 2025, Shuttle Pharmaceuticals Holdings, Inc. entered into a Revolving Loan Agreement with a lender, allowing the company to access up to $2 million for general corporate purposes. The agreement includes a high interest rate of 18% per annum and necessitated significant board changes, with four directors resigning and three new directors appointed. The loan agreement also outlines plans for a public equity offering and includes various covenants and conditions, potentially impacting the company’s strategic direction and governance.
More about Shuttle Pharmaceuticals Holdings, Inc.
YTD Price Performance: -27.88%
Average Trading Volume: 87,559
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.5M
See more insights into SHPH stock on TipRanks’ Stock Analysis page.